66111-59-9

Upstream product

• 13347-83-6 benzyl 4,6-O-benzylidene-2-amino-2-deoxy-α-D-glucopyranoside 
• 13343-63-0 benzyl 4,6-O-benzylidene-2-acetylamino-2-deoxy-α-D-glucopyranoside 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 177361-86-3 N-[(2S,3R,4R,5S,6R)-4-Azido-2-benzyloxy-6-benzyloxymethyl-5-(4-methoxy-benzyloxy)-tetrahydro-pyran-3-yl]-2,2,2-trifluoro-acetamide 
• 177361-89-6 N-((4aR,6S,7R,8R,8aS)-8-Azido-6-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl)-2,2,2-trifluoro-acetamide 
• 177361-90-9 N-((2S,3R,4R,5S,6R)-4-Azido-2-benzyloxy-6-benzyloxymethyl-5-hydroxy-tetrahydro-pyran-3-yl)-2,2,2-trifluoro-acetamide 

Relevant academic research and scientific papers

A facile synthesis of benzyl 2-amino-3-azido-4-O-p-methoxybenzyl-6-O-benzyl-2,3-dideoxy-α-D- glucopyranoside: A key intermediate in the formation of a didemnin B analog

Although the deprotection of amides by hydrazinolysis is a well established method in carbohydrate chemistry, this reaction is dependent upon the nearby substituents. In our facile synthesis of intermediate benzyl 2-amino-3-azido-4-O-p-methoxybenzyl-6-O-b

Novel immunological adjuvant compounds and methods of preparation thereof

This application relates to novel immunological adjuvant compounds of the formula: STR1 wherein each of R and R1 are the same or different and are hydrogen or an acyl radical; R2 is an unsubstituted or substituted alkyl radical, or an unsubstituted or substituted aryl radical; X is an aminoacyl moiety; and Y is D-isoasparagine or D-isoglutamine.

Novel immunological adjuvant compounds and methods of preparation thereof

This application relates to novel immunological adjuvant compounds of the formula: STR1 wherein each of R and R1 are the same or different and are hydrogen or an acyl radical; R2 is an unsubstituted or substituted alkyl radical, or an unsubstituted or substituted aryl radical; R6 is an alkyl radical X is an aminoacyl moiety; and Y is D-isoasparagine or D-isoglutamine.